These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33406870)

  • 61. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Arch Neurol; 2006 Jan; 63(1):60-5. PubMed ID: 16286536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
    Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
    Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Impact of N-Terminal Prohormone of Brain Natriuretic Peptide on Patients Hospitalized with Community-Acquired Pneumonia.
    Seo H; Cha SI; Shin KM; Lim JK; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY
    Am J Med Sci; 2020 Oct; 360(4):383-391. PubMed ID: 32690276
    [TBL] [Abstract][Full Text] [Related]  

  • 66. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
    D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
    Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis.
    Chen L; Chen YY; Ling YS; Lin CH; He JX; Guan TJ
    Ren Fail; 2017 Nov; 39(1):372-378. PubMed ID: 28209075
    [TBL] [Abstract][Full Text] [Related]  

  • 71. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role and Clinical Significance of Plasma N-Terminal Brain Natriuretic Peptide Measurement in Children with Brain Edema.
    Taskesen M; Celik H; Yaramis A; Tas MA
    Neuropediatrics; 2016 Jan; 47(1):20-3. PubMed ID: 26569156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Usefulness of Serum B-Type Natriuretic Peptide Levels in Comatose Patients Resuscitated from Out-of-Hospital Cardiac Arrest to Predict Outcome.
    Frydland M; Kjaergaard J; Erlinge D; Stammet P; Nielsen N; Wanscher M; Pellis T; Friberg H; Hovdenes J; Horn J; Wetterslev J; Thomsen JH; Bro-Jeppesen J; Winther-Jensen M; Wise MP; Kuiper M; Cronberg T; Gasche Y; Devaux Y; Åneman A; Hassager C
    Am J Cardiol; 2016 Oct; 118(7):998-1005. PubMed ID: 27614855
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early Fibrinogen Depletion and Symptomatic Intracranial Hemorrhage After Reperfusion Therapy.
    Yan S; Zhang X; Zhang R; Xu J; Lou M
    Stroke; 2019 Oct; 50(10):2716-2721. PubMed ID: 31394994
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic value of a single prehospital measurement of N-terminal pro-brain natriuretic peptide and troponin T after acute ischaemic stroke.
    Hajdinjak E; Klemen P; Grmec S
    J Int Med Res; 2012; 40(2):768-76. PubMed ID: 22613442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.
    Sabatine MS; Morrow DA; Higgins LJ; MacGillivray C; Guo W; Bode C; Rifai N; Cannon CP; Gerszten RE; Lee RT
    Circulation; 2008 Apr; 117(15):1936-44. PubMed ID: 18378613
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between increased N-terminal pro-brain natriuretic peptide level and poor clinical outcomes after acute ischemic stroke.
    Yang J; Zhong C; Wang A; Xu T; Bu X; Peng Y; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    J Neurol Sci; 2017 Dec; 383():5-10. PubMed ID: 29246621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults With Congenital Heart Disease.
    Popelová JR; Kotaška K; Tomková M; Tomek J
    Am J Cardiol; 2015 Nov; 116(9):1425-30. PubMed ID: 26404943
    [TBL] [Abstract][Full Text] [Related]  

  • 80. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.